About us
We developed a rapid tomographic bioprinter to help biologists push the frontiers of biofabrication.
We are Readily3D, we developed Tomolite and Apparite to make research in biosciences quicker and more efficient. Founded in 2020, Readily3D originates from a research work started in 2017 at Ecole Polytechnique Fédérale de Lausanne. Existing bioprinting technologies are slow, which tends to reduce cell viability. They also have a poor ability to produce complex anatomical structures, such as vasculatures. To overcome these limitations, we created Tomolite: a unique bioprinter, allowing biologists to print an entire cell-laden volume at once, in less than a minute and without impairing cell viability.
Currently, our team collaborates with biologists to explore innovative applications of tomographic 3D printing in biosciences. Since 2019, pilot tests of Tomolite and Apparite have begun in European life sciences laboratories. We are continuously looking for more users to further explore the potential of our technology.
Team
Damien Loterie
Co-founder and CEO
Damien graduated from EPFL in 2017 with a PhD in microenginering. His expertise in light shaping through complex media put him on the track of developing Readily3D’s algorithm for volumetric 3D printing. After having secured initial funding for Readily3D, Damien now works on establishing new business partnerships to foster the commercialization of volumetric 3D printing.
Paul Delrot
Co-founder and CTO
Paul holds a PhD in Photonics from EPFL. During his PhD studies, at the forefront of additive manufacturing, Paul acquired a multidisciplinary background and pioneered micro-additive manufacturing through endoscopic probes. Paul focuses on the product development of our tomographic bioprinter and the creation of bespoke applications for Readily3D’s customers.
Christophe Moser
Co-founder and advisor
Christophe Moser co-founded Ondax Inc. in 2000, where he was CEO for 10 years, before joining EPFL as associate professor. He co-founded Composyt Light Labs in 2014, which was subsequently acquired by Intel in 2016. In Readily3D, he has an advisory role and helps with business development establishing partnerships.
Press releases
Publications
Supported by
You don’t find the information you need?
Let us know! Give us a call or write to us – we will be more than happy to assist you.
Request a quote
Interested in our products? Reach out to us and we will provide you with a quote.
Schedule a meeting
Feel free to contact us and we will schedule an online meeting to discuss our products.
About us
We developed a rapid tomographic bioprinter to help biologists push the frontiers of biofabrication.
We are Readily3D, we developed Tomolite and Apparite to make research in biosciences quicker and more efficient. Founded in 2020, Readily3D originates from a research work started in 2017 at Ecole Polytechnique Fédérale de Lausanne. Existing bioprinting technologies are slow, which tends to reduce cell viability. They also have a poor ability to produce complex anatomical structures, such as vasculatures. To overcome these limitations, we created Tomolite: a unique bioprinter, allowing biologists to print an entire cell-laden volume at once, in less than a minute and without impairing cell viability.
Currently, our team collaborates with biologists to explore innovative applications of tomographic 3D printing in biosciences. Since 2019, pilot tests of Tomolite and Apparite have begun in European life sciences laboratories. We are continuously looking for more users to further explore the potential of our technology.
Team
Damien Loterie
Co-founder and CEO
Damien graduated from EPFL in 2017 with a PhD in microenginering. His expertise in light shaping through complex media put him on the track of developing Readily3D’s algorithm for volumetric 3D printing. After having secured initial funding for Readily3D, Damien now works on establishing new business partnerships to foster the commercialization of volumetric 3D printing.
Paul Delrot
Co-founder and CTO
Paul holds a PhD in Photonics from EPFL. During his PhD studies, at the forefront of additive manufacturing, Paul acquired a multidisciplinary background and pioneered micro-additive manufacturing through endoscopic probes. Paul focuses on the product development of our tomographic bioprinter and the creation of bespoke applications for Readily3D’s customers.
Christophe Moser
Co-founder and advisor
Christophe Moser co-founded Ondax Inc. in 2000, where he was CEO for 10 years, before joining EPFL as associate professor. He co-founded Composyt Light Labs in 2014, which was subsequently acquired by Intel in 2016. In Readily3D, he has an advisory role and helps with business development establishing partnerships.
Press releases
Publications
Supported by
You don’t find the information you need?
Let us know! Give us a call or write to us – we will be more than happy to assist you.
Request a quote
Interested in our products? Reach out to us and we will provide you with a quote.
Schedule a meeting
Feel free to contact us and we will schedule an online meeting to discuss our products.
